If you stop taking a GLP-1 medication, your appetite and metabolism may gradually return to pre-treatment levels, which can lead to weight regain
I'd rather tell you in person than guess online
Mechanisms underlying cardiovascular effects of incretin therapy In addition to glycemic effects, GLP-1RAs also favorably modulate multiple cardiovascular risk factors via acting on a variety of organ systems
Vitamin B12 and folate deficiencies (megaloblastic anemia) interfere with effective erythropoiesis and are associated with reduced red cell turnover, often producing falsely elevated HbA1c levels, although variability may occur depending on disease severity and treatment status
This may indicate rhabdomyolysis (a breakdown of muscle tissue), which is especially relevant for people taking statin medications
Realistic Expectations : Do you understand that results require time and consistency